Hekmatdoost A - Search Results

1

Validity and reproducibility of the PERSIAN Cohort food frequency questionnaire: assessment of major dietary patterns.

Eghtesad S, Masoudi S, Sharafkhah M, Rashidkhani B, Esmaeili-Nadimi A, Najafi F, Faramarzi E, Homayounfar R, Ebrahimnejad P, Ansari-Moghaddam A, Mirjalili M, Poustchi H, Willett WC, Malekzadeh R, Hekmatdoost A. Eghtesad S, et al. Among authors: hekmatdoost a. Nutr J. 2024 Mar 13;23(1):35. doi: 10.1186/s12937-024-00938-0. Nutr J. 2024. PMID: 38481332 Free PMC article.

2

Effect of nutrition intervention on non-communicable disease risk factors among Tehranian adults: Tehran Lipid and Glucose Study.

Mirmiran P, Ramezankhani A, Hekmatdoost A, Azizi F. Mirmiran P, et al. Among authors: hekmatdoost a. Ann Nutr Metab. 2008;52(2):91-5. doi: 10.1159/000121364. Epub 2008 Mar 18. Ann Nutr Metab. 2008. PMID: 18349527

3

Dietary fatty acid composition and metabolic syndrome in Tehranian adults.

Hekmatdoost A, Mirmiran P, Hosseini-Esfahani F, Azizi F. Hekmatdoost A, et al. Nutrition. 2011 Oct;27(10):1002-7. doi: 10.1016/j.nut.2010.11.004. Nutrition. 2011. PMID: 21907897

4

Intake of food groups and idiopathic asthenozoospermia: a case-control study.

Eslamian G, Amirjannati N, Rashidkhani B, Sadeghi MR, Hekmatdoost A. Eslamian G, et al. Among authors: hekmatdoost a. Hum Reprod. 2012 Nov;27(11):3328-36. doi: 10.1093/humrep/des311. Epub 2012 Aug 30. Hum Reprod. 2012. PMID: 22940769

5

How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?

Ghaemi A, Taleban FA, Hekmatdoost A, Rafiei A, Hosseini V, Amiri Z, Homayounfar R, Fakheri H. Ghaemi A, et al. Among authors: hekmatdoost a. Hepat Mon. 2013 Dec 7;13(12):e15227. doi: 10.5812/hepatmon.15227. eCollection 2013. Hepat Mon. 2013. PMID: 24358045 Free PMC article.

6

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study.

Eslamparast T, Poustchi H, Zamani F, Sharafkhah M, Malekzadeh R, Hekmatdoost A. Eslamparast T, et al. Among authors: hekmatdoost a. Am J Clin Nutr. 2014 Mar;99(3):535-42. doi: 10.3945/ajcn.113.068890. Epub 2014 Jan 8. Am J Clin Nutr. 2014. PMID: 24401715 Free article. Clinical Trial.

7

Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.

Askari F, Rashidkhani B, Hekmatdoost A. Askari F, et al. Among authors: hekmatdoost a. Nutr Res. 2014 Feb;34(2):143-8. doi: 10.1016/j.nutres.2013.11.005. Epub 2013 Dec 6. Nutr Res. 2014. PMID: 24461315 Clinical Trial.

8

Probiotics and Nonalcoholic Fatty liver Disease.

Eslamparast T, Eghtesad S, Hekmatdoost A, Poustchi H. Eslamparast T, et al. Among authors: hekmatdoost a. Middle East J Dig Dis. 2013 Jul;5(3):129-36. Middle East J Dig Dis. 2013. PMID: 24829682 Free PMC article. Review.

9

Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study.

Eslamparast T, Zamani F, Hekmatdoost A, Sharafkhah M, Eghtesad S, Malekzadeh R, Poustchi H. Eslamparast T, et al. Among authors: hekmatdoost a. Br J Nutr. 2014 Aug 14;112(3):438-45. doi: 10.1017/S0007114514000919. Epub 2014 May 22. Br J Nutr. 2014. PMID: 24848793 Clinical Trial.

10

Systematic review of zinc biomarkers and esophageal cancer risk.

Hashemian M, Hekmatdoost A, Poustchi H, Mohammadi Nasrabadi F, Abnet CC, Malekzadeh R. Hashemian M, et al. Among authors: hekmatdoost a. Middle East J Dig Dis. 2014 Oct;6(4):177-85. Middle East J Dig Dis. 2014. PMID: 25349680 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

264 results

Search Page